Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medios AGMEDOF 88 Earnings Yield (Joel Greenblatt) % is 21.88% as of Mar. 2026, which is 207% above its 10-year median of 7.12. GuruFocus rates MEDOF with a GF Score™ of 88/100 and a GF Value™ of $70.91. The stock has 2 warning signs investors should review. Among 120 Medical Distribution companies, Medios AG ranks better than 67.5% on this metric.
Medios AG's Enterprise Value for the quarter that ended in Mar. 2026 was $1,167 Mil.
Medios AG's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was $52 Mil. Medios AG's Earnings Yield (Joel Greenblatt) for the quarter that ended in Mar. 2026 was 21.88%.
The historical rank and industry rank for Medios AG's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
MEDOF'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: 1.38 Med: 7.12 Max: 22.3
Current: 10.75
During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of Medios AG was 22.30%. The lowest was 1.38%. And the median was 7.12%.
MEDOF's Earnings Yield (Joel Greenblatt) % is ranked better than 67.5% of 120
companies
in the Medical Distribution industry
Industry Median: 6.4
vs MEDOF: 10.75
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Medios AG's Forward Rate of Return (Yacktman) % for the quarter that ended in Mar. 2026 was 35.13%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Medios AG (OTCPK:MEDOF) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Medios AG Earnings Yield (Joel Greenblatt) % Related Terms
Medios AG Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Medios AG's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medios AG Earnings Yield (Joel Greenblatt) % Chart
For the Medical Distribution subindustry, Medios AG's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medios AG Earnings Yield (Joel Greenblatt) % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medios AG's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Medios AG's Earnings Yield (Joel Greenblatt) % falls into.
Medios AG Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Medios AGs Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2025 is calculated as
Medios AG's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $52 Mil.
What does a Earnings Yield (Joel Greenblatt) % of 21.88% mean?
Medios AG (MEDOF) has a Earnings Yield (Joel Greenblatt) % of 21.88% as of Mar. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Medios AG and its competitors. This is 207% above median its historical median of 7.12. Over the past decade, Medios AG's Earnings Yield (Joel Greenblatt) % has ranged from 1.38 to 22.30. According to the industry distribution chart, Medios AG ranks #39 out of 120 companies in the Medical Distribution industry, placing it in the top 32.5%.
Is Medios AG's Earnings Yield (Joel Greenblatt) % too high?
Medios AG's current Earnings Yield (Joel Greenblatt) % of 21.88% is 207% above median its 10-year median of 7.12. Over the past 10 years, this metric has ranged from a low of 1.38 to a high of 22.30. The Medical Distribution industry median Earnings Yield (Joel Greenblatt) % is 6.40. Medios AG's value of 21.88% is 241.9% above this industry median. Based on the distribution chart, Medios AG ranks #39 out of 120 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Medios AG has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Medios AG's Earnings Yield (Joel Greenblatt) % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Medios AG ranks #39 out of 120 companies for Earnings Yield (Joel Greenblatt) %. This puts Medios AG in the upper half of its industry. The industry median Earnings Yield (Joel Greenblatt) % is 6.40. Medios AG's value of 21.88% is 241.9% above this benchmark. Historically, Medios AG's own Earnings Yield (Joel Greenblatt) % has ranged from 1.38 to 22.30 over the past decade. While the company's 10-year median is 7.12 vs. the industry median of 6.40, Medios AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Medical Distribution company?
The median Earnings Yield (Joel Greenblatt) % among Medical Distribution companies is 6.40, based on 120 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medios AG's current Earnings Yield (Joel Greenblatt) % of 21.88% is 241.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Medios AG and its competitors. For the Medical Distribution industry, the median Earnings Yield (Joel Greenblatt) % is 6.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medios AG's current Earnings Yield (Joel Greenblatt) % is 21.88%, which is 207% above median its own 10-year median of 7.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medios AG stock overvalued right now?
Medios AG (MEDOF) has a current Earnings Yield (Joel Greenblatt) % of 21.88%. The stock's GF Value™ is $70.91, compared to a current price of $50.00 — trading 29.5% below its estimated fair value. The current Earnings Yield (Joel Greenblatt) % is 21.88%, which is 207% above median its 10-year median of 7.12 and 241.9% above the Medical Distribution industry median of 6.40. Medios AG's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For Medios AG (MEDOF), the current Earnings Yield (Joel Greenblatt) % is 21.88% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medios AG (MEDOF) Overvalued in 2026?
Based on GuruFocus' analysis, Medios AG stock appears to be undervalued.
The current stock price of $50.00 is trading 29.5% below its estimated GF Value™ of $70.91.
Key valuation signals for MEDOF:
Earnings Yield (Joel Greenblatt) %: 21.88% (207% above median its 10-year median of 7.12)
GF Value™: $70.91 vs. price of $50.00 (29.5% below fair value)
Industry Position: 241.9% above the Medical Distribution median (#39 of 120)
No single metric tells the full story. See the MEDOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medios AG is engaged as a wholesaler for pharmaceutical medicinal products. The operating segments of the company includes: Patient-Specific Therapies: This area includes the compounding of medications on behalf of pharmacies in Germany. Pharmaceautical Supply: Medios is speciality pharma supplier company in germany, producing it own production facilities, hospitals, and Pharmacies. International Business: It includes all business and activities happening in international business.
88GF Score
Get the complete analysis for MEDOF
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEDOF has been successfully added to your 
